Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEffectiveness and Tolerability of Fixed-Dose Combination Enalapril plus Nitrendipine in Hypertensive Patients: Results of the 3-Month Observational, Post-Marketing, Multicentre, Prospective CENIT Study
Clinical Drug Investigation, 07/29/09
De la Sierra A et al. – The proportion and type of adverse events reported were as expected and have already been described for both components of the enalapril/nitrendipine 10 mg/20 mg combination. These results confirm the effectiveness of a strategy based on a fixed–dose enalapril/nitrendipine 10 mg/20 mg combination in reducing BP and achieving BP control goals.
Related Articles
Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease
Nephrology Dialysis Transplantation, 11/17/09
Relevance Score: 84%
Pseudomelanosis Duodeni: An Unusual Finding From Upper Gastrointestinal Endoscopy
Clinical Gastroenterology and Hepatology, 11/04/09
Relevance Score: 80%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
Expert Opinion in Pharmacotherapy, 12/09/09
Complications and side-effects of foam sclerotherapy
Phlebology, 12/09/09
Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review
Headache: The Journal of Head and Face Pain, 12/08/09
Sponsor
Article Search
Sponsor